| NCT ID | NCT04353960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alaska Blind Child Discovery |
| Condition | Bradycardia |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 1992-09-01 |
| Primary Completion | 2035-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 1992-09-01 with a primary completion date of 2035-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observation study monitoring vital signs and anesthetic variables particularly heart rate during prospective, ocular manipulation and specifically uniform tension on extra ocular muscles during strabismus surgery. \*IRB approval from 1992 covered in letter from then IRB chair Dr. Judith Whitcomb, Anchorage, Alaska (letter 10/2020).\*
Eligibility Criteria
Inclusion Criteria: * Patient scheduled for ocular manipulation and tension on extra ocular muscles and strabismus surgery Exclusion Criteria: * anophthalmia
Frequently Asked Questions
Who can join the NCT04353960 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 100 Years, studying Bradycardia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04353960 currently recruiting?
Yes, NCT04353960 is actively recruiting participants. Visit ClinicalTrials.gov or contact Alaska Blind Child Discovery to inquire about joining.
Where is the NCT04353960 trial being conducted?
This trial is being conducted at Anchorage, United States.
Who is sponsoring the NCT04353960 clinical trial?
NCT04353960 is sponsored by Alaska Blind Child Discovery. The trial plans to enroll 4,000 participants.